Evidence map›Paper›PMID 23840494›Full record

ArticlePloS one2013

Anticancer activity of Amauroderma rude.

Chunwei Jiao, Yi-Zhen Xie, Xiangling Yang, Haoran Li, Xiang-Min Li, Hong-Hui Pan, Mian-Hua Cai, Hua-Mei Zhong, Burton B Yang

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed, 1 pooled it
3.8field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 1 synthesis or guideline pooled it, 43 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Review
  5. Taxonomy and phylogeny ofFrontiers in microbiology · 2022
    Article
  6. Anticancer Activity ofCancers · 2018
    Article
  7. Article
  8. Hypouricemic Effects ofFrontiers in pharmacology · 2017
    Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 2 countries.

Chunwei JiaoGuangdong Institute of Microbiology, Guangzhou, China.
Yi-Zhen Xie
Xiangling Yang
Haoran Li
Xiang-Min Li
Hong-Hui Pan
Mian-Hua Cai
Hua-Mei Zhong
Burton B Yang
Institute of Microbiology · CNSunnybrook Health Science Centre · CASunnybrook Research InstituteUniversity of Toronto · CA

Funding

Canadian Institutes of Health Research MOP-102635Canadian Institutes of Health Research MOP-111171
6 · The paper itself

Abstract

More and more medicinal mushrooms have been widely used as a miraculous herb for health promotion, especially by cancer patients. Here we report screening thirteen mushrooms for anti-cancer cell activities in eleven different cell lines. Of the herbal products tested, we found that the extract of Amauroderma rude exerted the highest activity in killing most of these cancer cell lines. Amauroderma rude is a fungus belonging to the Ganodermataceae family. The Amauroderma genus contains approximately 30 species widespread throughout the tropical areas. Since the biological function of Amauroderma rude is unknown, we examined its anti-cancer effect on breast carcinoma cell lines. We compared the anti-cancer activity of Amauroderma rude and Ganoderma lucidum, the most well-known medicinal mushrooms with anti-cancer activity and found that Amauroderma rude had significantly higher activity in killing cancer cells than Ganoderma lucidum. We then examined the effect of Amauroderma rude on breast cancer cells and found that at low concentrations, Amauroderma rude could inhibit cancer cell survival and induce apoptosis. Treated cancer cells also formed fewer and smaller colonies than the untreated cells. When nude mice bearing tumors were injected with Amauroderma rude extract, the tumors grew at a slower rate than the control. Examination of these tumors revealed extensive cell death, decreased proliferation rate as stained by Ki67, and increased apoptosis as stained by TUNEL. Suppression of c-myc expression appeared to be associated with these effects. Taken together, Amauroderma rude represented a powerful medicinal mushroom with anti-cancer activities.

Indexed as

AgaricalesAnimalsAntineoplastic AgentsApoptosisBreast NeoplasmsCell Line, TumorCell SurvivalFemaleFruiting Bodies, FungalFungal PolysaccharidesMedicine, Chinese TraditionalMiceMice, Inbred BALB CMice, NudeTumor BurdenXenograft Model Antitumor AssaysAntineoplastic AgentsFungal Polysaccharides

Identifiers

PMID23840494
PMCPMC3688780
OpenAlexW2063668654

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.